Effect of MyopiaEd Messaging on Improving Eye-use Behavior and Myopia Control Among Primary Schoo… (NCT07211893) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effect of MyopiaEd Messaging on Improving Eye-use Behavior and Myopia Control Among Primary School Students in China
1,330 participantsStarted 2025-12-05
Plain-language summary
Myopia represents a significant global public health challenge, with China experiencing particularly high myopia prevalence among children and adolescents. The World Health Organization (WHO) acknowledges the critical role of health education in eye care and has collaborated with the International Telecommunication Union (ITU) to launch the Be He@lthy, Be Mobile (BHBM) initiative, which includes MyopiaEd-a mobile health project specifically designed to address myopia. Developed in partnership with international experts and informed by evidence-based guidelines, MyopiaEd provides standardized, scientifically validated content for effective myopia control. The MyopiaEd library has been translated and adapted by the Zhongshan Ophthalmic Center for use in China. Therefore, we aim to investigate whether the Chinese version of MyopiaEd can improve eye care behaviors among primary school students and enhance parental knowledge regarding myopia prevention and control in China.
Who can participate
Age range
8 Years – 12 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* primary school students in the third grade;
* the guardians of students can receive, read, and understand multimedia (image-text) messages via WeChat on their mobile phones;
* voluntary participation in this study, with guardians' consent and a signed informed consent form.
Exclusion Criteria:
* with other ocular diseases that severely affect vision
* with systematic diseases or mental disorders, inability to understand or cooperate with the study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The proportion of children having improved eye-use behaviors after 1 year.
Timeframe: 12 months
Trial details
NCT IDNCT07211893
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University